Atıf Formatları
Efficacy and safety of a new high purity factor X concentrate in the treatment of severe or moderate factor X deficiency
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

K. Kavakli Et Al. , "Efficacy and safety of a new high purity factor X concentrate in the treatment of severe or moderate factor X deficiency," HAEMOPHILIA , vol.20, pp.20, 2014

Kavakli, K. Et Al. 2014. Efficacy and safety of a new high purity factor X concentrate in the treatment of severe or moderate factor X deficiency. HAEMOPHILIA , vol.20 , 20.

Kavakli, K., Austin, S., Alvarez, M. T., Auerswald, G., Bermejo, N., Mitchell, W., ... Oner, A.(2014). Efficacy and safety of a new high purity factor X concentrate in the treatment of severe or moderate factor X deficiency. HAEMOPHILIA , vol.20, 20.

Kavakli, K. Et Al. "Efficacy and safety of a new high purity factor X concentrate in the treatment of severe or moderate factor X deficiency," HAEMOPHILIA , vol.20, 20, 2014

Kavakli, K. Et Al. "Efficacy and safety of a new high purity factor X concentrate in the treatment of severe or moderate factor X deficiency." HAEMOPHILIA , vol.20, pp.20, 2014

Kavakli, K. Et Al. (2014) . "Efficacy and safety of a new high purity factor X concentrate in the treatment of severe or moderate factor X deficiency." HAEMOPHILIA , vol.20, p.20.

@article{article, author={K. Kavakli Et Al. }, title={Efficacy and safety of a new high purity factor X concentrate in the treatment of severe or moderate factor X deficiency}, journal={HAEMOPHILIA}, year=2014, pages={20} }